TNF and autoimmune disease: The NF-κB pathway has long been proposed as a therapeutic target in inflammatory and autoimmune diseases, but complete inhibition of TNF-α using neutralizing reagents has resulted in disease exacerbation, risk of infection, and other side effects related to immune regulation and tissue regeneration (reviewed by Fischer et al., 2015).